GT, B., NJ, M., AJ, P., BL, M., A, B., TJ, P., . . . VR, N. (2021). Late-onset complications with bendamustine versus CHOP or CVP based chemoimmunotherapy in indolent Non-Hodgkin's lymphoma. Leukemia & lymphoma, 62(13), 3138. https://doi.org/10.1080/10428194.2021.1953014
Chicago Style (17th ed.) CitationGT, Baek, Mathis NJ, Perissinotti AJ, Marini BL, Brown A, Phillips TJ, Wilcox RA, and Nachar VR. "Late-onset Complications with Bendamustine Versus CHOP or CVP Based Chemoimmunotherapy in Indolent Non-Hodgkin's Lymphoma." Leukemia & Lymphoma 62, no. 13 (2021): 3138. https://doi.org/10.1080/10428194.2021.1953014.
MLA (9th ed.) CitationGT, Baek, et al. "Late-onset Complications with Bendamustine Versus CHOP or CVP Based Chemoimmunotherapy in Indolent Non-Hodgkin's Lymphoma." Leukemia & Lymphoma, vol. 62, no. 13, 2021, p. 3138, https://doi.org/10.1080/10428194.2021.1953014.